Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹11.59
0.20 (1.76%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹225 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹9.3+24.6%
52W High₹24.89-53.4%
Current Price
₹11.59
Circuit Limits (5%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹11.01
Upper Circuit₹12.17
Reference Price
₹11.59
Investment Checklist
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹10.37
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹14.04
Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Composite score -58.8 (STRONG_SELL) with 90.5% confidence
20/50 Bearish Cross detected 1 day(s) ago
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
91%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
EMA20
12
EMA50
12.12
EMA200
14.22
Price Action
MIXED
NEUTRAL
Higher Highs2
Higher Lows2
Lower Highs7
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹11.72
₹12.79
₹13.06
₹13.51
₹13.92
Support (Below)
₹11.13
₹9.30
Volume Analysis
TrendSTABLE
Change-0.60%
Unusual VolumeNo
Recent MA Crossovers
20/50 Bearish Cross
1 day ago
SELL
Stop Loss Levels
Fixed Risk
1% Risk₹11.47
3% Risk₹11.24
5% Risk₹11.01
7% Risk (Custom)
₹10.78Technical Levels
1x ATR (Volatility)₹11.06
2x ATR (Swing)₹10.53
3x ATR (Trend)₹10.00
Immediate Support₹11.13
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹428.9 Cr | ₹280.7 Cr | ₹5 Cr | ₹0 |
| Net Profit | ₹-130.1 Cr | ₹-63.2 Cr | ₹-32,93,000 | ₹14.3 Cr |
| EPS | — | ₹-2.82 | ₹-7.85 | ₹0.64 |
| Operating Profit | ₹-151.8 Cr | ₹-61.5 Cr | ₹-30,21,000 | ₹86.9 Cr |
ROE
-11.89%
ROCE
-5.49%
Debt/Equity
0.61
Current Ratio
1.21
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 24 Dec 2025 | Buy Back | BUYBACK |
| 13 Sept 2024 | Annual General Meeting | AGM |
| 14 Sept 2023 | Annual General Meeting | AGM |
| 13 Sept 2022 | Annual General Meeting | AGM |
| 13 Sept 2021 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for NECLIFE
View All
positive
Business Standard - Markets 92d ago
Stocks to Watch today: ACME Solar, Gravita India, Kalpataru, Raymond Realty
Stocks to Watch today, March 13: Aurobindo Pharma, Godrej Properties, KPI Green Energy, JK Lakshmi Cement, Max Financial Services, and Nectar Lifesciences are among the top stocks to remain in focus
ACMESOLARADANIGREENAUROPHARMACLEANMAXENERGYFOCUSGKENERGYGODREJINDGODREJPROPGRAVITAINOXGREENJKCEMENTJKLAKSHMIJMFINANCILKALPATARUKPELKPIGREENMAXINDMFSLNECLIFENTPCGREENRAYMONDRAYMONDRELSAATVIKGLSOLARINDSCapital GoodsChemicals
positive
CNBC TV18 - Markets 92d ago
Nectar Lifesciences signs ₹100-crore loan pact with arm Avensis Exports
Nectar Lifesciences Ltd signed a ₹100-crore, 10-year loan deal at 12% interest with subsidiary Avensis Exports to support its corporate needs. Shares of Nectar Lifesciences Ltd ended marginally lower on Thursday, March 12, by 0.61% 11.35 on the NSE.
NECLIFEHealthcare
positive
Moneycontrol NaNd ago
Stocks to Watch Today: JK Lakshmi Cement, Gravita India, Balaji Amines, Shaily Engineering, Kalpataru, Action Construction Equipment in focus on 13 March
Stocks to Watch, 13 March: Stocks like Shaily Engineering Plastics, JK Lakshmi Cement, Max Financial Services, Manorama Industries, Nectar Lifesciences, Balaji Amines, and KPI Green Energy will be in focus on March 13.
ACEADANIGREENBALAMINESCLEANMAXENERGYFOCUSGARUDAGENCONGKENERGYGRAVITAHGINFRAIL&FSENGGINOXGREENJKCEMENTJKLAKSHMIJMFINANCILKALPATARUKPELKPIGREENMANORAMAMAXINDMBELMFSLNECLIFENTPCGREENSAATVIKGLSATTVAENGGSHAILYCapital GoodsChemicals